Univo Pharmaceuticals Ltd Stock TEL AVIV STOCK EXCHANGE
Equities
UNVO
IL0010935588
Biotechnology & Medical Research
Sales 2019 | 0.82 3.04 1.12 | Sales 2020 | 33.68 124.1 45.91 | Capitalization | 75.1M 277M 102M |
---|---|---|---|---|---|
Net income 2019 | -11M -40.53M -14.99M | Net income 2020 | - 0 0 | EV / Sales 2019 | 35,543,010 x |
Net cash position 2019 | 22.82M 84.09M 31.1M | Net Debt 2020 | 4.12M 15.18M 5.62M | EV / Sales 2020 | 2,352,105 x |
P/E ratio 2019 * |
-
| P/E ratio 2020 |
-
| Employees | - |
Yield 2019 * |
-
| Yield 2020 |
-
| Free-Float | 59.28% |
Managers | Title | Age | Since |
---|---|---|---|
Golan Bitton
CEO | Chief Executive Officer | 48 | 93-04-03 |
Jonathan Eilat
IRC | Investor Relations Contact | - | - |
Noam Frakash
AUD | Comptroller/Controller/Auditor | 41 | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chaim Hurvitz
CHM | Chairman | 63 | 19-07-14 |
Golan Bitton
CEO | Chief Executive Officer | 48 | 93-04-03 |
1st Jan change | Capi. | |
---|---|---|
+29.77% | 49.46B | |
+1.00% | 42.58B | |
+49.45% | 42.49B | |
-5.26% | 29.09B | |
+13.68% | 26.61B | |
-22.99% | 18.64B | |
+8.22% | 13.16B | |
+32.41% | 12.55B | |
+24.01% | 12.1B |